back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-06-12 17:07 Tx date 2023-06-07 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
64,000 | |
| Filed 2022-10-21 21:44 Tx date 2022-10-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez Family Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,040
+4,000 vol $5.26 each |
4,000 | |
| Filed 2022-10-21 21:43 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-21 21:42 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,144
+600 vol $5.24 each |
10,000 | |
| Filed 2022-10-21 21:41 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,108
+400 vol $5.27 each |
9,400 | |
| Filed 2022-10-21 21:41 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$236.70
+45 vol $5.26 each |
9,000 | |
| Filed 2022-10-21 21:41 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,018
+2,655 vol $5.28 each |
8,955 | |
| Filed 2022-10-21 21:41 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$555.45
+105 vol $5.29 each |
6,300 | |
| Filed 2022-10-21 21:40 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,833
+6,195 vol $5.30 each |
6,195 | |
| Filed 2022-10-21 21:39 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-21 21:38 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,144
+600 vol $5.24 each |
||
| Filed 2022-10-21 21:38 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,108
+400 vol $5.27 each |
||
| Filed 2022-10-21 21:37 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$236.70
+45 vol $5.26 each |
||
| Filed 2022-10-21 21:37 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,018
+2,655 vol $5.28 each |
||
| Filed 2022-10-21 21:37 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$555.45
+105 vol $5.29 each |
||
| Filed 2022-10-21 21:37 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,833
+6,195 vol $5.30 each |
||
| Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,144
+600 vol $5.24 each |
10,127 | |
| Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,144
+600 vol $5.24 each |
||
| Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,108
+400 vol $5.27 each |
||
| Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,108
+400 vol $5.27 each |
9,527 | |
| Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$236.70
+45 vol $5.26 each |
||
| Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$236.70
+45 vol $5.26 each |
9,127 | |
| Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,018
+2,655 vol $5.28 each |
||
| Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,018
+2,655 vol $5.28 each |
9,082 | |
| Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$555.45
+105 vol $5.29 each |
||
| Filed 2022-10-21 10:56 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$555.45
+105 vol $5.29 each |
6,427 | |
| Filed 2022-10-21 10:55 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,833
+6,195 vol $5.30 each |
||
| Filed 2022-10-21 10:55 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,833
+6,195 vol $5.30 each |
6,322 | |
| Filed 2022-10-21 10:55 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,000
+10,000 vol $5.00 each |
||
| Filed 2022-10-21 10:49 Tx date 2022-10-20 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,000
+10,000 vol $5.00 each |
||
| Filed 2022-09-16 15:54 Tx date 2022-09-14 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
+127 vol |
127 | |
| Filed 2020-06-08 16:22 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
34,000 | |
| Filed 2019-11-15 14:51 Tx date 2019-11-12 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+19,000 vol |
19,000 | |
| Filed 2019-05-22 16:43 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-05-22 16:43 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|